Summary of Important Announcements from the Beijing Stock Exchange (March 26, 2026)

On the evening of March 26, multiple listed companies on the Beijing Stock Exchange issued announcements. The following are some important announcements compiled by Tongbi Finance:

Yizhi Amorphophallus (920273): Plans to implement the 2025 annual equity distribution; cash dividend of 5 yuan for every 10 shares

On March 26, Hubei Yizhi Amorphophallus Biotechnology Co., Ltd. issued an announcement stating that, in order to actively fulfill the obligation to return value to shareholders and share the company’s operating results with all shareholders, and while taking into overall account strategic development goals and liquidity needs, and under the premise of ensuring the company’s ongoing, stable, and healthy development, the company plans to implement the 2025 annual equity distribution. The company’s current total share capital is 103.170886 million shares. Based on 103.037904 million shares after deducting 1.32982 million shares held in the repurchase special account, cash dividends of 5 yuan per 10 shares will be distributed to all shareholders out of undistributed profits. This equity distribution is expected to distribute a total of RMB 51.52 million in cash dividends.

Zhongke Meiling (920992): Plans to implement the 2025 annual equity distribution; cash dividend of 0.9 yuan for every 10 shares

On March 26, Zhongke Meiling Cryogenic Technology Co., Ltd. issued an announcement stating that the company’s current total share capital is 96.730934 million shares. Using undistributed profits, it will distribute cash dividends of 0.9 yuan per 10 shares to all shareholders. This equity distribution is expected to distribute a total of RMB 8.71 million in cash dividends.

Jikang Technology (920879): Plans to implement the 2025 annual equity distribution; cash dividend of 1.5 yuan for every 10 shares and bonus issue of 2 shares for every 10 shares

On March 26, Jikang Technology Co., Ltd. issued an announcement stating that, in order to actively fulfill the obligation to return value to shareholders and share the company’s operating results with all shareholders, the company has set a proposal for the 2025 annual equity distribution. The company’s current total share capital is 167.390679 million shares. It will distribute cash dividends of 1.5 yuan per 10 shares to all shareholders using undistributed profits; and it will increase share capital to all shareholders by 2 shares for every 10 shares to all shareholders using capital reserve. This equity distribution is expected to distribute RMB 25.11 million in cash dividends and issue an additional 33.478135 million shares.

Shichang Co., Ltd. (920022): Plans to implement the 2025 annual equity distribution; cash dividend of 6 yuan for every 10 shares

On March 26, Hebei Shichang Automotive Parts Co., Ltd. issued an announcement stating that the company’s current total share capital is 60.321 million shares. Using undistributed profits, it will distribute cash dividends of 6 yuan per 10 shares to all shareholders. This equity distribution is expected to distribute a total of RMB 36.19 million in cash dividends.

Compo Chem (920033): Plans to implement the 2025 annual equity distribution; cash dividend of 0.5 yuan for every 10 shares

On March 26, Chongqing Compo Chem Industrial Co., Ltd. issued an announcement stating that, in order to actively fulfill the obligation to return value to shareholders and share the company’s operating results with all shareholders, the company plans to implement the 2025 annual equity distribution. The company’s current total share capital is 119.13525 million shares. Using undistributed profits, it will distribute cash dividends of 0.5 yuan per 10 shares to all shareholders. This equity distribution is expected to distribute a total of RMB 5.96 million in cash dividends.

Hongyuan Co., Ltd. (920018): Plans to increase its investment in its Saudi subsidiary to advance its construction progress

On March 26, Shenyang Hongyuan Magnet Wire Co., Ltd. issued an announcement stating that the company plans to use its own funds or raised funds to make an additional investment amount in its Saudi subsidiary. After this additional investment, the project’s total investment amount will not exceed USD 36 million. After the capital increase, the equity structure of the Saudi subsidiary will remain unchanged. The additional investment in this round is mainly intended to meet capital needs such as engineering construction and supporting works, equipment procurement and installation, and working capital for laying-in.

Runong Water Saving (920964): Plans to establish a wholly owned subsidiary to further deepen the company’s business layout in the Xiangyang region

On March 26, Hebei Runong Water Saving Technology Co., Ltd. issued an announcement stating that, to further deepen the company’s business layout in the Xiangyang region, it currently plans to establish Runong Water Saving Technology (Zaoyang) Co., Ltd., with capital contribution from Hubei Runong Water Saving Technology Co., Ltd. The Zaoyang company will serve as the main entity to build a water-saving equipment production base, in order to address shortcomings in regional agricultural water-saving equipment.

Yongshun Biotech (920729): Obtained a new veterinary drug registration certificate, further enriching the company’s product categories

On March 26, Guangdong Yongshun Biopharmaceutical Co., Ltd. issued an announcement stating that, following review and approval by the Ministry of Agriculture and Rural Affairs of the People’s Republic of China, the “goose newcastle disease, gosling parvoviral hepatitis inactivated bivalent vaccine (A-VII strain + GPVP3/Bac strain)” jointly submitted by the company and other entities has been approved as a new veterinary drug, and the company has been issued a “New Veterinary Drug Registration Certificate.” It will publish product quality standards, production process regulations, the package insert, and labels, effective from the date of publication (Announcement No. 1002 of the Ministry of Agriculture and Rural Affairs).

Aiwet (920693): Recognized as a 7th batch of national-level specialized and innovative “little giant” enterprises; a precision machinery component manufacturer

On March 26, Shanghai Aiwet Precision Machinery Co., Ltd. issued an announcement stating that the company passed the 2025 re-evaluation of the specialized and innovative “little giant” enterprise.

Dingjia Precision (920005): First repurchase of 14,600 shares; 0.0176% of the company’s total share capital

On March 26, Suzhou Dingjia Precision Technology Co., Ltd. issued an announcement stating that the company has completed its first share repurchase. As of March 25, 2026, through its repurchase-dedicated securities account and via the continuous bidding transfer method, the company repurchased 14,600 shares, representing 0.0176% of the company’s total share capital; it represents 2.92% of the upper limit of the total number of shares expected to be repurchased. The highest transaction price was 34.6 yuan per share, and the lowest transaction price was 34.45 yuan per share. The total amount paid was 500,000 yuan, representing 1.6533% of the upper limit of the repurchase funds planned by the company.

Ke Chuangxin Material (920580): Held a 2025 performance briefing; responded to concerns about accounts receivable and the number of shareholders

Luoyang Ke Chuangxin Materials Co., Ltd. held a performance briefing for its 2025 annual report on March 25, 2026. The event was attended by Chairman Wei Wenxu Mr., Board Secretary Li Qing Ms., Financial负责人 Wang Minmin Ms., as well as the sponsor representatives Li Shuyao Mr. and Liu Yang Mr.; they held an online discussion with investors participating through the internet.

Wuxi Crystal Sea (920547): Uses own funds of RMB 30 million to purchase wealth management products to improve utilization efficiency of own funds

On March 26, Wuxi Crystal Sea Amino Acid Co., Ltd. issued an announcement stating that, for this round, the total amount of idle own funds used to purchase wealth management products is RMB 30 million. As of now, the balance of wealth management products purchased with idle own funds that have not yet matured is RMB 172 million.

Guozi Software (920953): Uses RMB 82 million of raised funds to purchase wealth management products to improve efficiency in use of raised funds

On March 26, Shandong Guozi Software Co., Ltd. issued an announcement stating that the amount of cash management using raised funds for this round is RMB 82 million. As of now, the balance of raised-funds cash management that has not yet matured is RMB 108 million.

Zitonggong (920566): Several shareholders plan to reduce their holdings; all due to capital needs

On March 26, Sichuan Zitonggong Pharmaceutical Co., Ltd. issued an announcement stating that its controlling shareholder, actual controller, and chairman Tang Xi plan to reduce their holdings by no more than 1.0 million shares, with a planned reduction ratio of no more than 0.69%; the controlling shareholder, actual controller, and chairman’s person acting in concert, Neijiang Jucai Enterprise Management Consulting Service Center (Limited Partnership), plans to reduce holdings by no more than 363,600 shares, with a planned reduction ratio of no more than 0.25%; and Director Wang Boyu plans to reduce holdings by no more than 12,000 shares, with a planned reduction ratio of no more than 0.01%.